Cite
HARVARD Citation
Bagnoli, M. et al. (n.d.). Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study. Lancet oncology. 17 (8), pp. 1137-1146. [Online].